isoproterenol has been researched along with farnesol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Barreto, TO; Conceição, MRL; Cruz, JS; Durço, AO; Guimarães, AG; Heimfarth, L; Menezes-Filho, JER; Quintans-Júnior, LJ; Rabelo, TK; Rhana, P; Santana, MNS; Souza, DS; Vasconcelos, CML | 1 |
1 other study(ies) available for isoproterenol and farnesol
Article | Year |
---|---|
Myocardial hypertrophy is prevented by farnesol through oxidative stress and ERK1/2 signaling pathways.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Apoptosis Regulatory Proteins; Blood Pressure; Cardiomegaly; Electrocardiography; Farnesol; Isoproterenol; Lipid Peroxidation; Male; MAP Kinase Signaling System; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Ventricular Function, Left | 2020 |